Drug Profile
Trivalent anti-TRAIL-R1 nano-agonist molecule1
Alternative Names: TTR nano-agonist molecule1; TTR1 agonist; TTR1 nano-agonistLatest Information Update: 08 Feb 2017
Price :
$50
*
At a glance
- Originator Teikyo University
- Developer SymBio Pharmaceuticals; Teikyo University
- Class Antibodies
- Mechanism of Action TRAIL receptor 1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer